Abstract
Hepatocellular adenomas (HCAs) are clinically relevant benign liver lesions that commonly occur in women on hormonal contraceptives. In this issue of Cancer Cell, Pilati and colleagues present an integrative multi-"omics"-based analysis of HCA and identify recurrent genetic alterations associated with adenoma-carcinoma transition and new drugable targets.
Original language | English |
---|---|
Journal | Cancer Cell |
Volume | 25 |
Issue number | 4 |
Pages (from-to) | 409-411 |
Number of pages | 3 |
ISSN | 1535-6108 |
DOIs | |
Publication status | Published - 14.04.2014 |